| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |